申请人:Innate Tumor Immunity, Inc.
公开号:US11344543B2
公开(公告)日:2022-05-31
The present invention provides compounds of Formula (I): (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).
本发明提供了式 (I) 的化合物:(I),其中所有变量如本文所定义。这些化合物是 NLRP3 的调节剂,可用作治疗受试者(例如人类)增殖性疾病(如癌症)的药物。